Evidence map›Paper›PMID 35056031›Full record

ArticlePathogens (Basel, Switzerland)2022

Ultraviolet-C Irradiation, Heat, and Storage as Potential Methods of Inactivating SARS-CoV-2 and Bacterial Pathogens on Filtering Facepiece Respirators.

Rhodri Harfoot, Deborah B Y Yung, William A Anderson, Cervantée E K Wild, Nicolene Coetzee, Leonor C Hernández, Blair Lawley, Daniel Pletzer, José G B Derraik, Yvonne C Anderson and 1 more

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Efficacy of Dry Heat Treatment againstPathogens (Basel, Switzerland) · 2022
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rhodri HarfootDepartment of Microbiology & Immunology, School of Biomedical Sciences, University of Otago, Dunedin 9016, New Zealand.
Deborah B Y YungDepartment of Microbiology & Immunology, School of Biomedical Sciences, University of Otago, Dunedin 9016, New Zealand.ORCID 0000-0002-4086-3869
William A AndersonDepartment of Chemical Engineering, University of Waterloo, Waterloo, ON N2L 3G1, Canada.ORCID 0000-0003-3580-8635
Cervantée E K WildDepartment of Paediatrics, Child and Youth Health, University of Auckland, Auckland 1010, New Zealand.
Nicolene CoetzeeDepartment of Paediatrics, Child and Youth Health, University of Auckland, Auckland 1010, New Zealand.
Leonor C HernándezDepartment of Microbiology & Immunology, School of Biomedical Sciences, University of Otago, Dunedin 9016, New Zealand.
Blair LawleyDepartment of Microbiology & Immunology, School of Biomedical Sciences, University of Otago, Dunedin 9016, New Zealand.
Daniel PletzerDepartment of Microbiology & Immunology, School of Biomedical Sciences, University of Otago, Dunedin 9016, New Zealand.ORCID 0000-0001-5750-7505
José G B DerraikDepartment of Paediatrics, Child and Youth Health, University of Auckland, Auckland 1010, New Zealand.ORCID 0000-0003-1226-1956
Yvonne C AndersonDepartment of Paediatrics, Child and Youth Health, University of Auckland, Auckland 1010, New Zealand.ORCID 0000-0003-2054-338X
Miguel E Quiñones-MateuDepartment of Microbiology & Immunology, School of Biomedical Sciences, University of Otago, Dunedin 9016, New Zealand.ORCID 0000-0001-9170-5601

Funding

Ministry of Business, Innovation & Employment MBIEThe Medical Assurance Society Foundation MASWebster Family Chair in Viral Pathogenesis UoO
6 · The paper itself

Abstract

The arrival of SARS-CoV-2 to Aotearoa/New Zealand in February 2020 triggered a massive response at multiple levels. Procurement and sustainability of medical supplies to hospitals and clinics during the then upcoming COVID-19 pandemic was one of the top priorities. Continuing access to new personal protective equipment (PPE) was not guaranteed; thus, disinfecting and reusing PPE was considered as a potential alternative. Here, we describe part of a local program intended to test and implement a system to disinfect PPE for potential reuse in New Zealand. We used filtering facepiece respirator (FFR) coupons inoculated with SARS-CoV-2 or clinically relevant multidrug-resistant pathogens (

Indexed as

bacteriaCOVID-19disinfectionNew Zealandpersonal protective equipmentPPESARS-CoV-2UV-C

Identifiers

PMID35056031
PMCPMC8780977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.